Cancer Institute A national cancer institute
designated cancer center

Michael F. Clarke, M.D.

Publication Details

  • The prognostic role of a gene signature from tumorigenic breast-cancer cells.

    Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, Sherlock G, Lewicki J, Shedden K, Clarke MF. N Engl J Med. 2007; 356 (3): 217-26

    Breast cancers contain a minority population of cancer cells characterized by CD44 expression but low or undetectable levels of CD24 (CD44+CD24-/low) that have higher tumorigenic capacity than other subtypes of cancer cells.

    PubMedID: 17229949

Stanford Medicine Resources:

Footer Links: